Teva Pharmaceutical Industries Limited (TLV: TEVA)
Israel
· Delayed Price · Currency is ILS · Price in ILA
6,200.00
+118.00 (1.94%)
Nov 19, 2024, 5:24 PM IDT
TEVA Revenue
Teva Pharmaceutical Industries had revenue of $4.33B USD in the quarter ending September 30, 2024, with 12.52% growth. This brings the company's revenue in the last twelve months to $16.77B, up 9.81% year-over-year. In the year 2023, Teva Pharmaceutical Industries had annual revenue of $15.85B with 6.17% growth.
Revenue (ttm)
$16.77B
Revenue Growth
+9.81%
P/S Ratio
n/a
Revenue / Employee
$459.86K
Employees
36,472
Market Cap
69.87B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 15.85B | 921.00M | 6.17% |
Dec 31, 2022 | 14.93B | -953.00M | -6.00% |
Dec 31, 2021 | 15.88B | -781.00M | -4.69% |
Dec 31, 2020 | 16.66B | -228.00M | -1.35% |
Dec 31, 2019 | 16.89B | -1.38B | -7.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTeva Pharmaceutical Industries News
- 5 hours ago - Teva Pharmaceutical Industries Limited (TEVA) Jefferies London Healthcare Conference (Transcript) - Seeking Alpha
- 6 days ago - FMR LLC Bolsters Stake in Teva Pharmaceutical Industries Ltd - GuruFocus
- 10 days ago - Teva to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 12 days ago - Market Whales and Their Recent Bets on TEVA Options - Benzinga
- 13 days ago - Teva Pharmaceutical Industries Limited (TEVA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript - The Motley Fool
- 13 days ago - Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast - Benzinga
- 13 days ago - Teva Pharm CEO says will work productively with Trump administration - Reuters